In breast cancer tissues, a significant downregulation of SASH1 expression has been observed, whereas upregulation of SASH1 is able to block the proliferation and invasion of breast cancer cells through inhibition of the PI3K-Akt-mTOR (mammalian target of rapamycin) signaling route [2]. Here, AKT1 is linked to breast cancer.